Doximity reported strong fiscal Q2 2025 results with revenue reaching $136.8 million, up 20% YoY, while net income grew 44% to $44.2 million. The company achieved an adjusted EBITDA of $76.1 million, representing a 41% YoY increase and margins of 55.7%. Operating cash flow surged 430% to $68.3 million.The company's clinical workflow tools saw record usage with over 600,000 unique active prescribers. Looking ahead, Doximity provided Q3 guidance with expected revenue between $152-153 million and adjusted EBITDA of $83-84 million. For fiscal year 2025, the company updated its guidance to revenue of $535-540 million and adjusted EBITDA of $274-279 million.As the leading digital platform for U.S. medical professionals, Doximity's network includes more than 80% of U.S. physicians across all specialties. The company continues to focus on helping doctors improve productivity and provide better patient care through its digital tools and collaboration platform.

Doximity reported strong fiscal Q2 2025 results with revenue reaching $136.8 million, up 20% YoY, while net income grew 44% to $44.2 million. The company achieved an adjusted EBITDA of $76.1 million, representing a 41% YoY increase and margins of 55.7%. Operating cash flow surged 430% to $68.3 million.The company's clinical workflow tools saw record usage with over 600,000 unique active prescribers. Looking ahead, Doximity provided Q3 guidance with expected revenue between $152-153 million and adjusted EBITDA of $83-84 million. For fiscal year 2025, the company updated its guidance to revenue of $535-540 million and adjusted EBITDA of $274-279 million.As the leading digital platform for U.S. medical professionals, Doximity's network includes more than 80% of U.S. physicians across all specialties. The company continues to focus on helping doctors improve productivity and provide better patient care through its digital tools and collaboration platform.